Evidence on the risk of gastrointestinal (GI) bleeding associated with dabigatran etexilate (DE) is contrasting. We performed a meta-analysis of literature to address this issue.
The risk of gastrointestinal bleeding in patients receiving dabigatran etexilate: a systematic review and meta-analysis of the literature / DI MINNO, Matteo; Ambrosino, Pasquale; Di Minno, Alessandro; Tremoli, Elena; DI MINNO, Giovanni. - In: ANNALS OF MEDICINE. - ISSN 0785-3890. - 49:4(2017), pp. 329-342. [10.1080/07853890.2016.1268710]
The risk of gastrointestinal bleeding in patients receiving dabigatran etexilate: a systematic review and meta-analysis of the literature
DI MINNO, MATTEO;AMBROSINO, PASQUALE;Di Minno, Alessandro;DI MINNO, GIOVANNI
2017
Abstract
Evidence on the risk of gastrointestinal (GI) bleeding associated with dabigatran etexilate (DE) is contrasting. We performed a meta-analysis of literature to address this issue.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
